Harbour Investments
TAK icon

Harbour Investments’s Takeda Pharmaceutical TAK Stock Holding History

Harbour Investments’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$129K Sell
8,036
-71
-0.9% -$1.18K ﹤0.01% 1851
2026
Q1 		$150K Buy
8,107
+3,495
+76% +$61.3K ﹤0.01% 1689
2025
Q4 		$71.9K Buy
4,612
+3,460
+300% +$49.5K ﹤0.01% 1794
2025
Q3 		$16.9K Sell
1,152
-224
-16% -$3.33K ﹤0.01% 2441
2025
Q2 		$21.3K Hold
1,376
– – ﹤0.01% 2204
2025
Q1 		$20.5K Sell
1,376
-377
-22% -$5.28K ﹤0.01% 2181
2024
Q4 		$23.2K Hold
1,753
– – ﹤0.01% 2060
2024
Q3 		$24.9K Hold
1,753
– – ﹤0.01% 1960
2024
Q2 		$22.7K Sell
1,753
-285
-14% -$3.77K ﹤0.01% 1899
2024
Q1 		$28.3K Buy
2,038
+377
+23% +$5.48K ﹤0.01% 1787
2023
Q4 		$23.7K Buy
1,661
+55
+3% +$780 ﹤0.01% 1792
2023
Q3 		$24.8K Sell
1,606
-33
-2% -$511 ﹤0.01% 1650
2023
Q2 		$25.7K Buy
1,639
+1,211
+283% +$19.8K ﹤0.01% 1659
2023
Q1 		$7.05K Sell
428
-70
-14% -$1.11K ﹤0.01% 2164
2022
Q4 		$7.77K Hold
498
– – ﹤0.01% 2061
2022
Q3 		$7K Hold
498
– – ﹤0.01% 2079
2022
Q2 		$7K Buy
+498
New +$7.11K ﹤0.01% 2079
2021
Q4 		$6K Sell
424
-4,016
-90% -$56.3K ﹤0.01% 2134
2021
Q3 		$73K Sell
4,440
-212
-5% -$3.56K ﹤0.01% 1548
2021
Q2 		$78K Buy
4,652
+212
+5% +$3.61K ﹤0.01% 1541
2021
Q1 		$81K Buy
+4,440
New +$79.9K ﹤0.01% 1417

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Brandes Investment Partners
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Harbour Investments's TAK Position: Q2 2026 in Review

Harbour Investments reduced its Takeda Pharmaceutical (TAK) stake by 0.88% in Q2 2026, selling an estimated $1.18K and leaving 8,036 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #1851.

Harbour Investments first reported a position in TAK in Q1 2021 and has held it in 21 quarters since. The position peaked at $150K in Q1 2026. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Harbour Investments held 8,036 shares of Takeda Pharmaceutical worth $129K as of Q2 2026.
  • Harbour Investments sold 71 Takeda Pharmaceutical shares in Q2 2026, an estimated $1.18K.
  • Takeda Pharmaceutical made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #1851 holding.
  • Harbour Investments first reported a position in Takeda Pharmaceutical in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's Takeda Pharmaceutical position peaked at $150K in Q1 2026.
  • 379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.